Citreoviridin (CIT) produced by Penicillium citreonigrum as a secondary metabolite is a 28 yellow rice toxin that has been reported to be related to acute cardiac beriberi; however, its 29 toxicokinetics remain unclear. The present study elucidated the toxicokinetics through swine 30 in vivo experiments and predicted the human toxicokinetics by a comparison with findings 31 from in vitro experiments. Swine in vivo experiments revealed that CIT had a high 32 bioavailability of more than 90%. In addition, it showed a large volume of distribution (1.005 33 ± 0.195 L/kg) and long elimination half-life (17.7 ± 3.3 h) in intravenous. These results
10 140 mg/mL of CIT-ethanol solution and a small amount of water were added to feed (10 g) in 141 order to make 0.1 mg/kg·BW. This was then fashioned into a sphere and fed to the animals. It 142 was visually confirmed that the animals had eaten the CIT-contaminated feed.
143
Blood was sampled from the jugular vein at 0 min (before administration), and 5, 10, 144 20 and 30 min and 1, 2, 3, 4, 8, 24 and 48 h after administration. Blood samples were placed 145 into heparinized tubes and stored on ice until centrifugation. After centrifugation (1919 g, 10 146 min), the plasma was stored at -80 °C temporarily. Plasma samples were prepared according 147 to the method of Devreese et al. [15] . A 3-fold volume of acetonitrile was mixed with the 148 plasma samples, which were then centrifuged again (8500 g, 4 °C 10 min) after mixing with a 149 vortex mixer for 15 seconds. The supernatants were transferred into amber screw-top vials 150 and dried under nitrogen gas. The samples were stored at -30 °C until the analysis.
151
In order to frequently sample blood in a short period of time, up to 1 h after 152 administration, CIT was administered intravenously and orally, followed by immediately 
172
EDM containing CIT was exposed to Caco-2 cells from the apical (AP) side. The 12 174 measured at 0 (before exposure), 1 and 2 h (after exposure) using a Millicell ERS device 175 (Millipore, Molsheim, France). To determine the CIT concentration at the AP and BL sides, 176 transport buffer was collected from both sides. After 400 µL of collected buffer (per side)
177 was transferred to a micro tube, a three-fold volume of acetonitrile was added. Samples were 178 mixed with a vortex mixed, followed by centrifugation at 8500 g for 10 min at 4 °C. The 229 LC/MS system (Agilent Technologies, Ltd.). The drying gas temperature and fragmentor 230 voltage were 350 °C and 120 V, respectively, and the other conditions were as described 231 above.
232
To detect CIT glucuronide by incubation using S9 with UDPGA, dried samples were 233 re-dissolved in acetonitrile. MS was performed using the Agilent 6530 Q-TOF LC/MS 234 system (Agilent Technology, Ltd.). The mobile phases used were 5 mmol/L acetic 235 ammonium and methanol, and the solvent composition was increased in a linear gradient 236 from 10% organic modifier to 100% at 30 min. The flow rate was 0.2 mL/min, the column 237 temperature was 40 °C, and the injection volume was 3 µL. the ion source was the AJS 238 (Positive mode). Other conditions were as described above. Fig. 2A . The two-compartment model was described as follows:
where 278 Values are presented as the mean ± SD.
280
The CIT concentration profile in plasma after PO administration is shown in Fig. 2B .
281 The toxicokinetic parameters of PO administration were analyzed by a non-compartmental 282 analysis [16]. The peak plasma concentration (Cmax, 38.2 ± 6.7 ng/mL) was observed 283 between 15 ± 6 h (Tmax) after administration ( Table 2) . The mean residence time (MRT) 284 was obtained from equation (2) as follows:
The area under the first moment curve (AUMC) and AUC of PO and IV data were 287 calculated using the trapezoidal rule. The MRT obtained from those values was relatively 20 288 long (32.8 ± 11.8 h) ( Permeability study using Caco-2 cells 300 The results of the administration study showed that CIT had a high bioavailability in swine. 
305
The apparent permeability coefficient (Papp) estimated from a Caco-2 permeability 306 assay has been reported to correlate well with the human in vivo absorption data for many 307 agents [19] [20] . The TEER value is generally accepted to reflect the integrity of tight 308 junction dynamics in Caco-2 cells [21], so the TEER was measured at 1 and 2 h after 309 exposure to 3 and 10 µmol/L of CIT. Our results showed no marked change in the TEER 310 over time at any concentration (data not shown). The transport rate of CIT from the AP to BL 311 was calculated based on the concentration of CIT in the BL compartment. The Papp was 312 calculated as described in a previous paper [17] . The Papp at 3 and 10 µmol/L CIT after 313 incubation for 2 h was 52.2 × 10 -6 and 42.6 × 10 -6 (cm/s) in the AP-BL direction, respectively 314 (Table 3 ). These findings indicated that human intestine cells were highly permeable to CIT 320 Values are presented as the mean ± SD.
322
CIT elimination and the CIT metabolites profile following incubation with 323 S9 in vitro 324 The fact that it took more than 40 h to eliminate CIT in plasma after IV and PO 325 administration in swine in vivo experiments suggested that CIT was metabolized poorly in the 326 liver and other organs. Therefore, to confirm the CIT metabolic activity and its metabolites 327 produced in the liver and intestine, the residual CIT concentration after incubation in vitro 328 with hepatic or intestinal S9 from swine was measured, and the profile of CIT metabolites 329 produced was identified by using Q-TOF. These data obtained from the swine S9 fraction 23 330 were subsequently compared with those obtained using human S9.
331
The elimination of CIT as well as the metabolites produced when CIT was incubated 332 with S9 fractions supplemented with NADP was investigated. NADP is a coenzyme of 
344
The main metabolites could not be quantified because standard substances of the 345 metabolites detected were not commercially available. Therefore, comparison of metabolites 346 in humans and swine at each time was conducted with the mean area of each metabolite in 24 347 swine as 100% at 240 minutes. The rate of metabolite peak area by incubation with the 348 human hepatic S9 fraction was two to three times higher than with the swine hepatic S9
349 fraction for all metabolites (Fig. 3B-D) . These results indicate that human hepatic S9 has a 350 greater ability to metabolize CIT than swine hepatic S9. 362 Asterisks indicate a significant difference (p<0.05).
25 364
The concentration of CIT hardly decrease up to 240 min after incubation with the 365 human intestinal S9 fraction, whereas it increased from 30 to 60 min after incubation with the 366 swine intestinal S9 fraction, followed by almost no change from 60 to 240 min (Fig. 4A) .
367 Although the reason that the increase observed in incubation with swine intestinal S9 fraction 368 was unclear, these indicated that CIT was hardly metabolized either intestinal S9 fractions.
369 For the comparison, the same method as the comparison in S9 fractions supplemented with 370 NADP was used. The rate of metabolite peak area by incubation with the human intestinal S9 371 fraction was roughly three times higher than with the swine intestinal S9 fraction for all 372 metabolites ( Fig. 4B-D) . These were almost the same rates as in the above incubation using 373 hepatic S9.
374
The peak areas of CIT metabolites produced by incubation with intestinal S9 were 375 about one-third the size of those with hepatic S9 in both swine and humans (data not shown).
376 However, these findings showed that CIT was hardly metabolized at all in the intestine of 377 swine and humans.
378 
